---
category: listing
circular_id: 8f80867513bcd966
date: '2025-11-27'
description: BSE announces the listing and admission of equity shares of Sudeep Pharma
  Limited on the exchange, with specific date to be notified separately.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={3C5B5533-E7D9-4FD8-AADD-EA6ADD04996F}&noticeno=20251127-13&dt=11/27/2025&icount=13&totcount=62&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine new listing announcement for a single company with listing
  date to be announced later; limited immediate market impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251127-13&attachedId=
processing:
  attempts: 1
  content_hash: ed1e9d436a2c9cbf
  processed_at: '2025-11-27T15:45:04.877636'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-27T08:32:50+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={3C5B5533-E7D9-4FD8-AADD-EA6ADD04996F}&noticeno=20251127-13&dt=11/27/2025&icount=13&totcount=62&flag=0
severity: low
source: bse
stocks:
- SUDEEPPHRM
tags:
- equity
- ipo
- listing
- sudeep-pharma
title: Listing of Equity Shares of Sudeep Pharma Limited
---

## Summary

BSE has announced that equity shares of Sudeep Pharma Limited will be listed and admitted to trading on the exchange in due course. The company has been assigned scrip code 544619, symbol SUDEEPPHRM, and ISIN number INE0QPI01025. The exact listing date and additional security details will be communicated through a separate notice.

## Key Points

- Company Name: Sudeep Pharma Limited
- Scrip Code: 544619
- Trading Symbol: SUDEEPPHRM
- ISIN Number: INE0QPI01025
- Listing status: Approved for listing, exact date pending
- Notice issued by Hardik Bhuta, Assistant Vice President, BSE

## Regulatory Changes

No regulatory changes are introduced by this circular. This is a standard listing notification.

## Compliance Requirements

Trading members are informed of the upcoming listing and should prepare their systems to accommodate the new security once the listing date is announced. No immediate action required until the listing date notification.

## Important Dates

- Notice Date: November 27, 2025
- Listing Date: To be announced through separate notice

## Impact Assessment

This is a routine new listing announcement with minimal immediate market impact. The listing will add one new equity security to BSE's trading platform. Trading members and investors interested in the pharmaceutical sector should await the separate notice containing the listing date and final security details before trading can commence.